US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProQR Therapeutics NV

1.50

+0.04002.74%

Post-market: 1.500.00000.00%16:10 EST

Volume:357.43K

Turnover:530.08K

Market Cap:158.02M

PE:-3.11

High:1.52

Open:1.45

Low:1.43

Close:1.46

52wk High:3.10

52wk Low:1.07

Shares:105.35M

Float Shares:67.53M

Volume Ratio:0.77

T/O Rate:0.53%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4823

EPS(LYR):-0.3339

ROE:-103.76%

ROA:-24.02%

PB:2.34

PE(LYR):-4.49

Loading ...

Overview Company News Filings

BRIEF-Proqr Announces Encouraging Ax-0810 Phase 1

ProQR Reports Positive Initial Safety Data from AX-0810 Phase 1 Trial

ProQR Therapeutics Nv: Initial Ax-0810 Data Show No Safety Signals After 4 Weeks of Dosing and Pharmacokinetics Consistent With Non-Clinical Data

THOMSON REUTERS

ProQR Therapeutics Nv: Phase 1 Ax-0810 Data Expected in H1 2026

THOMSON REUTERS

ProQR Therapeutics to Participate in Evercore Healthcare Conference

ProQR Therapeutics N.V.'s (NASDAQ:PRQR) 29% Share Price Plunge Could Signal Some Risk

Simply Wall St.

ProQR Therapeutics Q3 EPS EUR -0.1

ProQR Q3 revenue misses estimates, reports net loss

BRIEF-ProQR Therapeutics Q3 EPS EUR -0.1

ProQR Therapeutics Q3 Revenue EUR 2.882 Million VS. Ibes Estimate EUR 4.37 Million

THOMSON REUTERS

ProQR Therapeutics NV expected to post a loss of 10 cents a share - Earnings Preview

ProQR Therapeutics NV held annual shareholder meeting

ProQR Therapeutics Receives CTA Authorization for Phase 1 Trial of AX-0810 in Europe

ProQR Therapeutics Nv - Receives Cta Authorization for Phase 1 Study of Ax-0810

THOMSON REUTERS

ProQR Therapeutics NV to Participate in Chardan's Annual Genetic Medicines Conference

ProQR Therapeutics N.V.'s (NASDAQ:PRQR) Price Is Out Of Tune With Revenues

Simply Wall St.

ProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary

ProQR Q2 revenue and EPS miss estimates

ProQR Therapeutics NV expected to post a loss of 8 cents a share - Earnings Preview

ProQR Therapeutics NV Submits CTA for AX-0810 to Target Cholestatic Diseases, Showcasing Progress in CNS Applications at Upcoming RNA Editing Summit

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PRQR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRQR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRQR\",,,,,undefined,":{"symbol":"PRQR","market":"US","secType":"STK","nameCN":"ProQR Therapeutics NV","latestPrice":1.5,"timestamp":1770411600000,"preClose":1.46,"halted":0,"volume":357433,"hourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.5,"latestTime":"16:10 EST","volume":4,"amount":6,"timestamp":1770412204934,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02739726027397263,"floatShares":67530657,"shares":105345192,"eps":-0.482307,"marketStatus":"Market Closed","change":0.04,"latestTime":"02-06 16:00:00 EST","open":1.45,"high":1.5197,"low":1.43,"amount":530083.207,"amplitude":0.061438,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.482307,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1411012800000,"exchange":"NASDAQ","adjPreClose":1.46,"preHourTrading":{"tag":"盘前","latestPrice":1.44,"preClose":1.46,"latestTime":"09:18 EST","volume":1306,"amount":1871.8800050000002,"timestamp":1770387526223,"change":-0.02,"changeRate":-0.013699,"amplitude":0.007055},"postHourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.5,"latestTime":"16:10 EST","volume":4,"amount":6,"timestamp":1770412204934,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7741346803526186,"impliedVol":0.9981,"impliedVolPercentile":0.6494},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRQR\",,,,,undefined,":{"symbol":"PRQR","floatShares":67530657,"roa":"-24.02%","roe":"-103.76%","lyrEps":-0.333887,"volumeRatio":0.7741346803526186,"shares":105345192,"dividePrice":0,"high":1.5197,"amplitude":0.061438,"preClose":1.46,"low":1.43,"week52Low":1.07,"pbRate":"2.34","psRate":"8.32","week52High":3.1,"institutionHeld":0,"latestPrice":1.5,"eps":-0.482307,"divideRate":0,"volume":357433,"delay":0,"ttmEps":-0.482307,"open":1.45,"prevYearClose":2.02,"prevWeekClose":1.62,"prevMonthClose":1.62,"prevQuarterClose":2.02,"fiveDayClose":1.62,"twentyDayClose":2.1,"sixtyDayClose":2.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRQR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"PRQR","fiscalQuarterEnding":"2025/09","expectedEps":-0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2025-08-07","symbol":"PRQR","fiscalQuarterEnding":"2025/06","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-05-08","symbol":"PRQR","fiscalQuarterEnding":"2025/03","expectedEps":-0.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2025-03-13","symbol":"PRQR","fiscalQuarterEnding":"2024/12","expectedEps":-0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2024-11-07","symbol":"PRQR","fiscalQuarterEnding":"2024/09","expectedEps":-0.12,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRQR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRQR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1745816400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PRQR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PRQR","date":"2026-02-06","current":-3.110052,"percent":0.64845,"low":-16.412594,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"high":-0.596848,"avg":-4.899599,"sd":3.22122,"marketCap":153803980},"quantilePoints":[{"date":"2021-02-12","current":-4.075121,"twenty":-7.877466,"median":-5.507972,"eighty":-3.12218,"marketCap":256247102},{"date":"2021-02-19","current":-3.951184,"twenty":-7.877466,"median":-5.499873,"eighty":-3.12218,"marketCap":248725171},{"date":"2021-02-26","current":-4.067593,"twenty":-7.877466,"median":-5.4869,"eighty":-3.12218,"marketCap":229168152},{"date":"2021-03-05","current":-4.185317,"twenty":-7.87974,"median":-5.463377,"eighty":-3.121338,"marketCap":232176924},{"date":"2021-03-12","current":-4.472406,"twenty":-7.87974,"median":-5.433793,"eighty":-3.121338,"marketCap":248725171},{"date":"2021-03-19","current":-5.103172,"twenty":-7.87974,"median":-5.410717,"eighty":-3.121338,"marketCap":282824590},{"date":"2021-03-26","current":-7.482539,"twenty":-7.887455,"median":-5.401458,"eighty":-3.12218,"marketCap":410926369},{"date":"2021-04-01","current":-7.645601,"twenty":-7.887455,"median":-5.43111,"eighty":-3.12218,"marketCap":418893304},{"date":"2021-04-09","current":-7.445043,"twenty":-7.895523,"median":-5.424027,"eighty":-3.121338,"marketCap":411976736},{"date":"2021-04-16","current":-7.113097,"twenty":-7.871083,"median":-5.424027,"eighty":-3.121338,"marketCap":396767322},{"date":"2021-04-23","current":-7.288239,"twenty":-7.854969,"median":-5.424027,"eighty":-3.121338,"marketCap":409331620},{"date":"2021-04-30","current":-7.342994,"twenty":-7.854969,"median":-5.424027,"eighty":-3.121338,"marketCap":411315457},{"date":"2021-05-07","current":-7.861736,"twenty":-7.856897,"median":-5.424027,"eighty":-3.121338,"marketCap":411976736},{"date":"2021-05-14","current":-8.099694,"twenty":-7.896763,"median":-5.424027,"eighty":-3.121338,"marketCap":423879755},{"date":"2021-05-21","current":-8.141773,"twenty":-7.984904,"median":-5.463377,"eighty":-3.121338,"marketCap":427847428},{"date":"2021-05-28","current":-7.852343,"twenty":-7.984904,"median":-5.470528,"eighty":-3.121338,"marketCap":412638014},{"date":"2021-06-04","current":-8.054822,"twenty":-8.00088,"median":-5.470528,"eighty":-3.121338,"marketCap":422557197},{"date":"2021-06-11","current":-8.570985,"twenty":-8.048804,"median":-5.470528,"eighty":-3.121338,"marketCap":447024516},{"date":"2021-06-18","current":-9.818903,"twenty":-8.079257,"median":-5.470528,"eighty":-3.121338,"marketCap":501910662},{"date":"2021-06-25","current":-9.15602,"twenty":-8.120797,"median":-5.470528,"eighty":-3.121338,"marketCap":471491834},{"date":"2021-07-02","current":-8.430733,"twenty":-8.15395,"median":-5.470528,"eighty":-3.121338,"marketCap":430492544},{"date":"2021-07-09","current":-8.234772,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":421234640},{"date":"2021-07-16","current":-7.273715,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":370316167},{"date":"2021-07-23","current":-7.157782,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":363042099},{"date":"2021-07-30","current":-6.761847,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":345848849},{"date":"2021-08-06","current":-6.518909,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":419852760},{"date":"2021-08-13","current":-6.529347,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":421864833},{"date":"2021-08-20","current":-5.798685,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":370892294},{"date":"2021-08-27","current":-6.794467,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":438632116},{"date":"2021-09-03","current":-7.122997,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":463447695},{"date":"2021-09-10","current":-8.491936,"twenty":-8.167753,"median":-5.470528,"eighty":-3.121338,"marketCap":549966874},{"date":"2021-09-17","current":-8.83899,"twenty":-8.212316,"median":-5.470528,"eighty":-3.121338,"marketCap":568075539},{"date":"2021-09-24","current":-8.149406,"twenty":-8.167753,"median":-5.470528,"eighty":-3.121338,"marketCap":522468530},{"date":"2021-10-01","current":-8.654141,"twenty":-8.162703,"median":-5.470528,"eighty":-3.121338,"marketCap":549296182},{"date":"2021-10-08","current":-8.203447,"twenty":-8.149326,"median":-5.470528,"eighty":-3.121338,"marketCap":519785765},{"date":"2021-10-15","current":-8.320782,"twenty":-8.15238,"median":-5.470528,"eighty":-3.121338,"marketCap":528504752},{"date":"2021-10-22","current":-7.824676,"twenty":-8.15238,"median":-5.470528,"eighty":-3.121338,"marketCap":498323643},{"date":"2021-10-29","current":-8.178311,"twenty":-8.162041,"median":-5.470528,"eighty":-3.121338,"marketCap":517773691},{"date":"2021-11-05","current":-9.146793,"twenty":-8.201922,"median":-5.481201,"eighty":-3.121338,"marketCap":598409942},{"date":"2021-11-12","current":-8.562754,"twenty":-8.24238,"median":-5.481201,"eighty":-3.121338,"marketCap":555005653},{"date":"2021-11-19","current":-8.625518,"twenty":-8.299175,"median":-5.481201,"eighty":-3.121338,"marketCap":552871016},{"date":"2021-11-26","current":-7.985271,"twenty":-8.308116,"median":-5.481201,"eighty":-3.121338,"marketCap":511601365},{"date":"2021-12-03","current":-7.348261,"twenty":-8.308116,"median":-5.481201,"eighty":-3.121338,"marketCap":469620168},{"date":"2021-12-10","current":-7.520518,"twenty":-8.308116,"median":-5.481201,"eighty":-3.121338,"marketCap":481716445},{"date":"2021-12-17","current":-8.281698,"twenty":-8.308116,"median":-5.481201,"eighty":-3.121338,"marketCap":528678462},{"date":"2021-12-23","current":-9.106985,"twenty":-8.345569,"median":-5.481201,"eighty":-3.121338,"marketCap":583467482},{"date":"2021-12-31","current":-8.851677,"twenty":-8.443858,"median":-5.481201,"eighty":-3.121338,"marketCap":569948113},{"date":"2022-01-07","current":-7.790788,"twenty":-8.489153,"median":-5.484397,"eighty":-3.12218,"marketCap":500216634},{"date":"2022-01-14","current":-7.438045,"twenty":-8.489153,"median":-5.484397,"eighty":-3.12218,"marketCap":481004899},{"date":"2022-01-21","current":-5.618039,"twenty":-8.489153,"median":-5.484397,"eighty":-3.12218,"marketCap":360753674},{"date":"2022-01-28","current":-5.854891,"twenty":-8.489153,"median":-5.502802,"eighty":-3.12218,"marketCap":370003769},{"date":"2022-02-04","current":-5.952741,"twenty":-8.489153,"median":-5.546321,"eighty":-3.12218,"marketCap":385657774},{"date":"2022-02-11","current":-1.531692,"twenty":-8.489153,"median":-5.589552,"eighty":-3.115687,"marketCap":98904853},{"date":"2022-02-18","current":-1.352949,"twenty":-8.489153,"median":-5.589552,"eighty":-2.993371,"marketCap":86808576},{"date":"2022-02-25","current":-1.088498,"twenty":-8.489153,"median":-5.589552,"eighty":-2.943204,"marketCap":75568253},{"date":"2022-03-04","current":-0.955778,"twenty":-8.489153,"median":-5.589552,"eighty":-2.917879,"marketCap":64282918},{"date":"2022-03-11","current":-1.02947,"twenty":-8.489153,"median":-5.50609,"eighty":-2.883893,"marketCap":69451502},{"date":"2022-03-18","current":-1.10861,"twenty":-8.489153,"median":-5.45436,"eighty":-2.853691,"marketCap":75568253},{"date":"2022-03-25","current":-0.942466,"twenty":-8.489153,"median":-5.343984,"eighty":-2.827898,"marketCap":63812399},{"date":"2022-04-01","current":-0.943355,"twenty":-8.489153,"median":-5.248209,"eighty":-2.809042,"marketCap":64161724},{"date":"2022-04-08","current":-0.989325,"twenty":-8.489153,"median":-5.169906,"eighty":-2.79609,"marketCap":66307577},{"date":"2022-04-14","current":-0.842377,"twenty":-8.489153,"median":-5.133326,"eighty":-2.78819,"marketCap":56098734},{"date":"2022-04-22","current":-0.80292,"twenty":-8.489153,"median":-5.098136,"eighty":-2.764386,"marketCap":53332651},{"date":"2022-04-29","current":-0.760779,"twenty":-8.489153,"median":-4.981596,"eighty":-2.733396,"marketCap":49404527},{"date":"2022-05-06","current":-0.678789,"twenty":-8.489153,"median":-4.91895,"eighty":-2.708705,"marketCap":45633244},{"date":"2022-05-13","current":-0.669176,"twenty":-8.489153,"median":-4.891957,"eighty":-2.696666,"marketCap":44200299},{"date":"2022-05-20","current":-0.717873,"twenty":-8.489153,"median":-4.883109,"eighty":-2.692655,"marketCap":48057131},{"date":"2022-05-27","current":-0.712869,"twenty":-8.489153,"median":-4.883109,"eighty":-2.689262,"marketCap":48463489},{"date":"2022-06-03","current":-0.822834,"twenty":-8.489153,"median":-4.883109,"eighty":-2.685958,"marketCap":55963281},{"date":"2022-06-10","current":-0.815564,"twenty":-8.489153,"median":-4.883109,"eighty":-2.677709,"marketCap":54459045},{"date":"2022-06-17","current":-0.787129,"twenty":-8.489153,"median":-4.883109,"eighty":-2.658676,"marketCap":52263289},{"date":"2022-06-24","current":-0.724232,"twenty":-8.489849,"median":-4.884777,"eighty":-2.618569,"marketCap":48477747},{"date":"2022-07-01","current":-0.8522,"twenty":-8.489849,"median":-4.884777,"eighty":-2.573268,"marketCap":56248445},{"date":"2022-07-08","current":-0.916161,"twenty":-8.489849,"median":-4.884777,"eighty":-2.514439,"marketCap":59171368},{"date":"2022-07-15","current":-0.890686,"twenty":-8.489849,"median":-4.884777,"eighty":-2.465673,"marketCap":57032644},{"date":"2022-07-22","current":-0.873686,"twenty":-8.489849,"median":-4.884777,"eighty":-2.409376,"marketCap":56676189},{"date":"2022-07-29","current":-0.922573,"twenty":-8.489849,"median":-4.884777,"eighty":-2.388231,"marketCap":59713178},{"date":"2022-08-05","current":-0.945118,"twenty":-8.489849,"median":-4.884777,"eighty":-2.361001,"marketCap":60086878},{"date":"2022-08-12","current":-0.956093,"twenty":-8.489849,"median":-4.884777,"eighty":-2.274685,"marketCap":61364259},{"date":"2022-08-19","current":-0.927788,"twenty":-8.489849,"median":-4.884777,"eighty":-2.219195,"marketCap":58309962},{"date":"2022-08-26","current":-0.90335,"twenty":-8.489849,"median":-4.884777,"eighty":-2.192301,"marketCap":56518773},{"date":"2022-09-02","current":-0.875124,"twenty":-8.489849,"median":-4.884777,"eighty":-2.165067,"marketCap":54955943},{"date":"2022-09-09","current":-0.892134,"twenty":-8.489849,"median":-4.884777,"eighty":-2.156993,"marketCap":56069192},{"date":"2022-09-16","current":-0.853137,"twenty":-8.489849,"median":-4.884777,"eighty":-2.139713,"marketCap":53521566},{"date":"2022-09-23","current":-0.891228,"twenty":-8.489849,"median":-4.884777,"eighty":-2.126751,"marketCap":54242323},{"date":"2022-09-30","current":-0.864972,"twenty":-8.489849,"median":-4.884777,"eighty":-2.122544,"marketCap":53093393},{"date":"2022-10-07","current":-0.962058,"twenty":-8.489849,"median":-4.884777,"eighty":-2.108014,"marketCap":58873722},{"date":"2022-10-14","current":-1.041103,"twenty":-8.489849,"median":-4.884777,"eighty":-2.088188,"marketCap":63512258},{"date":"2022-10-21","current":-1.055547,"twenty":-8.489849,"median":-4.884777,"eighty":-2.067935,"marketCap":64803912},{"date":"2022-10-28","current":-1.066265,"twenty":-8.489849,"median":-4.884777,"eighty":-2.044872,"marketCap":66366741},{"date":"2022-11-04","current":-1.063227,"twenty":-8.489849,"median":-4.884777,"eighty":-2.010069,"marketCap":65974250},{"date":"2022-11-11","current":-0.873744,"twenty":-8.489849,"median":-4.884777,"eighty":-2.005818,"marketCap":64926186},{"date":"2022-11-18","current":-1.20726,"twenty":-8.489849,"median":-4.884777,"eighty":-1.986496,"marketCap":90006595},{"date":"2022-11-25","current":-1.279522,"twenty":-8.489849,"median":-4.884777,"eighty":-1.97413,"marketCap":95721300},{"date":"2022-12-02","current":-1.278347,"twenty":-8.489849,"median":-4.884777,"eighty":-1.958524,"marketCap":96435638},{"date":"2022-12-09","current":-1.403815,"twenty":-8.489849,"median":-4.884777,"eighty":-1.944956,"marketCap":106436370},{"date":"2022-12-16","current":-1.460783,"twenty":-8.489849,"median":-4.884777,"eighty":-1.934484,"marketCap":111436737},{"date":"2022-12-23","current":-2.533365,"twenty":-8.489849,"median":-4.884777,"eighty":-1.934484,"marketCap":193587831},{"date":"2022-12-30","current":-3.43753,"twenty":-8.489849,"median":-4.884777,"eighty":-1.934484,"marketCap":264308108},{"date":"2023-01-06","current":-3.339793,"twenty":-8.489849,"median":-4.884777,"eighty":-1.934484,"marketCap":255021607},{"date":"2023-01-13","current":-3.147859,"twenty":-8.489849,"median":-4.884777,"eighty":-1.934484,"marketCap":245020760},{"date":"2023-01-20","current":-2.574673,"twenty":-8.489849,"median":-4.884777,"eighty":-1.953213,"marketCap":200731293},{"date":"2023-01-27","current":-2.643382,"twenty":-8.489849,"median":-4.884777,"eighty":-1.983247,"marketCap":206446063},{"date":"2023-02-03","current":-2.882133,"twenty":-8.489849,"median":-4.884777,"eighty":-2.005818,"marketCap":225019065},{"date":"2023-02-10","current":-2.696295,"twenty":-8.489849,"median":-4.884777,"eighty":-2.059922,"marketCap":207160409},{"date":"2023-02-17","current":-2.877245,"twenty":-8.489849,"median":-4.884777,"eighty":-2.097942,"marketCap":220732988},{"date":"2023-02-24","current":-2.738533,"twenty":-8.489849,"median":-4.884777,"eighty":-2.109951,"marketCap":207874755},{"date":"2023-03-03","current":-2.782022,"twenty":-8.489849,"median":-4.884777,"eighty":-2.130285,"marketCap":212160833},{"date":"2023-03-10","current":-2.662513,"twenty":-8.489849,"median":-4.884777,"eighty":-2.380808,"marketCap":204303024},{"date":"2023-03-17","current":-3.027197,"twenty":-8.489849,"median":-4.884777,"eighty":-2.495321,"marketCap":232162528},{"date":"2023-03-24","current":-3.156679,"twenty":-8.489849,"median":-4.884777,"eighty":-2.541503,"marketCap":244306414},{"date":"2023-03-31","current":-2.150852,"twenty":-8.489153,"median":-4.883109,"eighty":-2.570165,"marketCap":152155749},{"date":"2023-04-06","current":-2.230286,"twenty":-8.489153,"median":-4.883109,"eighty":-2.570165,"marketCap":158584865},{"date":"2023-04-14","current":-2.549337,"twenty":-8.489849,"median":-4.884777,"eighty":-2.582741,"marketCap":183454769},{"date":"2023-04-21","current":-2.512198,"twenty":-8.489849,"median":-4.884777,"eighty":-2.590326,"marketCap":179413915},{"date":"2023-04-28","current":-2.455027,"twenty":-8.489849,"median":-4.884777,"eighty":-2.590802,"marketCap":176181232},{"date":"2023-05-05","current":-2.413965,"twenty":-8.489849,"median":-4.884777,"eighty":-2.588833,"marketCap":172948549},{"date":"2023-05-12","current":-2.284785,"twenty":-8.489849,"median":-4.884777,"eighty":-2.55209,"marketCap":162442328},{"date":"2023-05-19","current":-2.17895,"twenty":-8.489849,"median":-4.884777,"eighty":-2.532081,"marketCap":140621717},{"date":"2023-05-26","current":-2.099623,"twenty":-8.490544,"median":-4.885901,"eighty":-2.516561,"marketCap":134964521},{"date":"2023-06-02","current":-2.326845,"twenty":-8.490544,"median":-4.885901,"eighty":-2.490457,"marketCap":149730998},{"date":"2023-06-09","current":-2.199538,"twenty":-8.490544,"median":-4.885901,"eighty":-2.461763,"marketCap":142042109},{"date":"2023-06-16","current":-2.101451,"twenty":-8.490544,"median":-4.885901,"eighty":-2.407048,"marketCap":137590647},{"date":"2023-06-23","current":-2.106885,"twenty":-8.49124,"median":-4.887025,"eighty":-2.378088,"marketCap":138400004},{"date":"2023-06-30","current":-2.009341,"twenty":-8.491936,"median":-4.891957,"eighty":-2.326845,"marketCap":131115793},{"date":"2023-07-07","current":-2.138252,"twenty":-8.491936,"median":-4.891957,"eighty":-2.252526,"marketCap":139209361},{"date":"2023-07-14","current":-2.026818,"twenty":-8.491936,"median":-4.891957,"eighty":-2.200147,"marketCap":135971934},{"date":"2023-07-21","current":-2.023323,"twenty":-8.491936,"median":-4.891957,"eighty":-2.180738,"marketCap":135162577},{"date":"2023-07-28","current":-1.855368,"twenty":-8.491936,"median":-4.891957,"eighty":-2.158582,"marketCap":122212869},{"date":"2023-08-04","current":-1.949306,"twenty":-8.491936,"median":-4.891957,"eighty":-2.139154,"marketCap":115743931},{"date":"2023-08-11","current":-2.073061,"twenty":-8.491936,"median":-4.879307,"eighty":-2.10324,"marketCap":123837912},{"date":"2023-08-18","current":-2.085602,"twenty":-8.491936,"median":-4.805763,"eighty":-2.099323,"marketCap":123028514},{"date":"2023-08-25","current":-2.246265,"twenty":-8.491936,"median":-4.737622,"eighty":-2.099323,"marketCap":131931893},{"date":"2023-09-01","current":-2.208699,"twenty":-8.491936,"median":-4.665409,"eighty":-2.099323,"marketCap":129908398},{"date":"2023-09-08","current":-2.189826,"twenty":-8.450172,"median":-4.630519,"eighty":-2.099323,"marketCap":127075504},{"date":"2023-09-15","current":-2.252827,"twenty":-8.353734,"median":-4.605695,"eighty":-2.099323,"marketCap":130313097},{"date":"2023-09-22","current":-2.071584,"twenty":-8.299672,"median":-4.527985,"eighty":-2.096017,"marketCap":119790921},{"date":"2023-09-29","current":-1.878698,"twenty":-8.262873,"median":-4.476713,"eighty":-2.085602,"marketCap":107649949},{"date":"2023-10-06","current":-1.842919,"twenty":-8.211528,"median":-4.440923,"eighty":-2.063039,"marketCap":105221755},{"date":"2023-10-13","current":-1.71172,"twenty":-8.181611,"median":-4.404761,"eighty":-2.046551,"marketCap":97937172},{"date":"2023-10-20","current":-1.905135,"twenty":-8.156841,"median":-4.396533,"eighty":-2.028059,"marketCap":109268746},{"date":"2023-10-27","current":-1.686623,"twenty":-8.141951,"median":-4.388402,"eighty":-2.023484,"marketCap":96318376},{"date":"2023-11-03","current":-1.659065,"twenty":-8.126694,"median":-4.36878,"eighty":-2.008991,"marketCap":95508978},{"date":"2023-11-10","current":-2.875672,"twenty":-8.087318,"median":-4.340044,"eighty":-2.004739,"marketCap":112808915},{"date":"2023-11-17","current":-2.897141,"twenty":-8.054289,"median":-4.31625,"eighty":-2.004739,"marketCap":115243640},{"date":"2023-11-24","current":-3.007747,"twenty":-8.027496,"median":-4.301977,"eighty":-2.004739,"marketCap":120113089},{"date":"2023-12-01","current":-3.149662,"twenty":-8.001658,"median":-4.27966,"eighty":-2.004739,"marketCap":125794114},{"date":"2023-12-08","current":-4.190572,"twenty":-7.975228,"median":-4.241633,"eighty":-2.006078,"marketCap":165561285},{"date":"2023-12-15","current":-4.111906,"twenty":-7.949693,"median":-4.22793,"eighty":-2.006078,"marketCap":165561285},{"date":"2023-12-22","current":-4.052328,"twenty":-7.905172,"median":-4.213672,"eighty":-2.003399,"marketCap":163126560},{"date":"2023-12-29","current":-3.941559,"twenty":-7.888349,"median":-4.21066,"eighty":-1.996445,"marketCap":159880261},{"date":"2024-01-05","current":-4.044578,"twenty":-7.867452,"median":-4.206213,"eighty":-1.993638,"marketCap":162314986},{"date":"2024-01-12","current":-4.06881,"twenty":-7.852764,"median":-4.183098,"eighty":-1.993638,"marketCap":163126560},{"date":"2024-01-19","current":-4.324369,"twenty":-7.792996,"median":-4.182503,"eighty":-1.990831,"marketCap":172053885},{"date":"2024-01-26","current":-4.273828,"twenty":-7.778543,"median":-4.179683,"eighty":-1.993638,"marketCap":169619160},{"date":"2024-02-02","current":-4.433092,"twenty":-7.726078,"median":-4.179683,"eighty":-1.993638,"marketCap":176111759},{"date":"2024-02-09","current":-4.323598,"twenty":-7.67285,"median":-4.179683,"eighty":-1.993638,"marketCap":170430735},{"date":"2024-02-16","current":-4.01693,"twenty":-7.621102,"median":-4.170988,"eighty":-1.993638,"marketCap":158257111},{"date":"2024-02-23","current":-4.159233,"twenty":-7.593706,"median":-4.141829,"eighty":-1.993638,"marketCap":164749710},{"date":"2024-03-01","current":-4.131179,"twenty":-7.574049,"median":-4.132942,"eighty":-1.996445,"marketCap":163532348},{"date":"2024-03-08","current":-3.974545,"twenty":-7.531723,"median":-4.125469,"eighty":-1.996445,"marketCap":159068686},{"date":"2024-03-15","current":-6.162546,"twenty":-7.506446,"median":-4.111906,"eighty":-1.996445,"marketCap":188742653},{"date":"2024-03-22","current":-6.39449,"twenty":-7.488802,"median":-4.111906,"eighty":-1.996445,"marketCap":195251020},{"date":"2024-03-28","current":-6.374943,"twenty":-7.473277,"median":-4.111906,"eighty":-1.996445,"marketCap":193623928},{"date":"2024-04-05","current":-5.806436,"twenty":-7.442244,"median":-4.111906,"eighty":-1.993638,"marketCap":177353010},{"date":"2024-04-12","current":-6.213229,"twenty":-7.380266,"median":-4.111906,"eighty":-1.993638,"marketCap":187115561},{"date":"2024-04-19","current":-5.046675,"twenty":-7.352793,"median":-4.111906,"eighty":-1.993638,"marketCap":151319541},{"date":"2024-04-26","current":-5.293618,"twenty":-7.339896,"median":-4.111906,"eighty":-1.996445,"marketCap":159455000},{"date":"2024-05-03","current":-5.381552,"twenty":-7.333212,"median":-4.111906,"eighty":-1.996445,"marketCap":161895638},{"date":"2024-05-10","current":-5.370404,"twenty":-7.289181,"median":-4.111906,"eighty":-1.996445,"marketCap":162709184},{"date":"2024-05-17","current":-5.110593,"twenty":-7.251533,"median":-4.111906,"eighty":-1.996445,"marketCap":156200816},{"date":"2024-05-24","current":-5.312032,"twenty":-7.215454,"median":-4.111906,"eighty":-1.996445,"marketCap":154341593},{"date":"2024-05-31","current":-5.133933,"twenty":-7.208104,"median":-4.111906,"eighty":-1.996445,"marketCap":149441860},{"date":"2024-06-07","current":-5.563428,"twenty":-7.183119,"median":-4.111906,"eighty":-1.996445,"marketCap":162507815},{"date":"2024-06-14","current":-5.058744,"twenty":-7.155503,"median":-4.111906,"eighty":-1.993638,"marketCap":146175372},{"date":"2024-06-21","current":-4.854503,"twenty":-7.127873,"median":-4.111906,"eighty":-1.990831,"marketCap":139642394},{"date":"2024-06-28","current":-4.688687,"twenty":-7.103668,"median":-4.107562,"eighty":-1.987953,"marketCap":134742661},{"date":"2024-07-05","current":-4.61487,"twenty":-7.077921,"median":-4.107562,"eighty":-1.987953,"marketCap":133926039},{"date":"2024-07-12","current":-4.841286,"twenty":-7.047459,"median":-4.107562,"eighty":-1.987953,"marketCap":141275638},{"date":"2024-07-15","current":-5.156274,"twenty":-7.036695,"median":-4.107562,"eighty":-1.987953,"marketCap":151075105},{"date":"2024-08-02","current":-5.133561,"twenty":-6.901199,"median":-4.09548,"eighty":-1.949326,"marketCap":148625238},{"date":"2024-08-09","current":-7.140139,"twenty":-6.86257,"median":-4.09548,"eighty":-1.949326,"marketCap":167815860},{"date":"2024-08-16","current":-7.697465,"twenty":-6.911401,"median":-4.09548,"eighty":-1.949326,"marketCap":182146834},{"date":"2024-08-23","current":-7.236585,"twenty":-6.93312,"median":-4.09548,"eighty":-1.949326,"marketCap":173162013},{"date":"2024-08-30","current":-6.811696,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":162543588},{"date":"2024-09-06","current":-6.446567,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":153967167},{"date":"2024-09-13","current":-6.356329,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":151108360},{"date":"2024-09-20","current":-6.059129,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":145390747},{"date":"2024-09-27","current":-6.038208,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":145390747},{"date":"2024-10-04","current":-6.264984,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":148657954},{"date":"2024-10-11","current":-6.524269,"twenty":-6.975717,"median":-4.09548,"eighty":-1.949326,"marketCap":153558766},{"date":"2024-10-18","current":-15.721494,"twenty":-7.01583,"median":-4.09548,"eighty":-1.949326,"marketCap":366744075},{"date":"2024-10-25","current":-12.110076,"twenty":-7.023279,"median":-4.09548,"eighty":-1.949326,"marketCap":281796672},{"date":"2024-10-31","current":-16.148416,"twenty":-7.060792,"median":-4.09548,"eighty":-1.949326,"marketCap":377725662},{"date":"2024-11-08","current":-14.267501,"twenty":-7.073439,"median":-4.092391,"eighty":-1.949322,"marketCap":368437326},{"date":"2024-11-15","current":-16.094368,"twenty":-7.098686,"median":-4.092391,"eighty":-1.949322,"marketCap":407654745},{"date":"2024-11-22","current":-14.835081,"twenty":-7.130789,"median":-4.092391,"eighty":-1.949322,"marketCap":372565476},{"date":"2024-11-29","current":-15.690865,"twenty":-7.14025,"median":-4.092391,"eighty":-1.949322,"marketCap":396302334},{"date":"2024-12-06","current":-14.437547,"twenty":-7.153344,"median":-4.092391,"eighty":-1.949322,"marketCap":365341214},{"date":"2024-12-13","current":-13.521478,"twenty":-7.154482,"median":-4.092391,"eighty":-1.949322,"marketCap":339540281},{"date":"2024-12-20","current":-10.753984,"twenty":-7.154482,"median":-4.092391,"eighty":-1.949322,"marketCap":267297668},{"date":"2024-12-27","current":-11.093016,"twenty":-7.154482,"median":-4.092391,"eighty":-1.949322,"marketCap":276586004},{"date":"2025-01-03","current":-11.517358,"twenty":-7.154482,"median":-4.092391,"eighty":-1.949322,"marketCap":282778228},{"date":"2025-01-10","current":-10.971159,"twenty":-7.153501,"median":-4.089301,"eighty":-1.949318,"marketCap":270393780},{"date":"2025-01-17","current":-9.63117,"twenty":-7.161996,"median":-4.089301,"eighty":-1.949318,"marketCap":237368585},{"date":"2025-01-24","current":-8.984838,"twenty":-7.177201,"median":-4.089301,"eighty":-1.949318,"marketCap":223952100},{"date":"2025-01-31","current":-8.890906,"twenty":-7.26829,"median":-4.089301,"eighty":-1.949318,"marketCap":221888025},{"date":"2025-02-07","current":-9.971289,"twenty":-7.296176,"median":-4.089301,"eighty":-1.949318,"marketCap":247688959},{"date":"2025-02-14","current":-9.369529,"twenty":-7.333672,"median":-4.089301,"eighty":-1.949318,"marketCap":234272473},{"date":"2025-02-21","current":-10.627937,"twenty":-7.333672,"median":-4.089301,"eighty":-1.949318,"marketCap":266265631},{"date":"2025-02-28","current":-9.693763,"twenty":-7.345472,"median":-4.089301,"eighty":-1.949318,"marketCap":241496735},{"date":"2025-03-07","current":-7.722265,"twenty":-7.421767,"median":-4.08841,"eighty":-1.949314,"marketCap":200215242},{"date":"2025-03-14","current":-5.953907,"twenty":-7.442244,"median":-4.08841,"eighty":-1.949314,"marketCap":179574495},{"date":"2025-03-21","current":-5.692868,"twenty":-7.442244,"median":-4.08841,"eighty":-1.949314,"marketCap":171496419},{"date":"2025-03-28","current":-5.020369,"twenty":-7.442244,"median":-4.08841,"eighty":-1.949314,"marketCap":150453913},{"date":"2025-04-04","current":-4.347953,"twenty":-7.442244,"median":-4.097034,"eighty":-1.949314,"marketCap":133619909},{"date":"2025-04-11","current":-3.828826,"twenty":-7.440844,"median":-4.09548,"eighty":-1.949318,"marketCap":118890155},{"date":"2025-04-17","current":-3.799201,"twenty":-7.440844,"median":-4.089301,"eighty":-1.949318,"marketCap":119942280},{"date":"2025-04-25","current":-5.139842,"twenty":-7.442244,"median":-4.08725,"eighty":-1.949314,"marketCap":162027291},{"date":"2025-05-02","current":-5.780364,"twenty":-7.442244,"median":-4.091173,"eighty":-1.949314,"marketCap":180965546},{"date":"2025-05-09","current":-4.791781,"twenty":-7.442244,"median":-4.101474,"eighty":-1.949314,"marketCap":163079416},{"date":"2025-05-16","current":-5.07944,"twenty":-7.442244,"median":-4.110156,"eighty":-1.949314,"marketCap":171496419},{"date":"2025-05-23","current":-5.227526,"twenty":-7.442244,"median":-4.110156,"eighty":-1.949314,"marketCap":178029607},{"date":"2025-05-30","current":-5.344536,"twenty":-7.442244,"median":-4.110156,"eighty":-1.949314,"marketCap":183296755},{"date":"2025-06-06","current":-5.455634,"twenty":-7.442244,"median":-4.130715,"eighty":-1.949314,"marketCap":188563903},{"date":"2025-06-13","current":-5.849843,"twenty":-7.442244,"median":-4.145599,"eighty":-1.949314,"marketCap":204365348},{"date":"2025-06-20","current":-5.904009,"twenty":-7.443643,"median":-4.131964,"eighty":-1.94931,"marketCap":204365348},{"date":"2025-06-27","current":-6.443873,"twenty":-7.443643,"median":-4.131964,"eighty":-1.94931,"marketCap":227540800},{"date":"2025-07-03","current":-6.468541,"twenty":-7.443643,"median":-4.131964,"eighty":-1.94931,"marketCap":229647659},{"date":"2025-07-11","current":-7.047118,"twenty":-7.443643,"median":-4.178422,"eighty":-1.94931,"marketCap":248609392},{"date":"2025-07-18","current":-7.227706,"twenty":-7.452141,"median":-4.206028,"eighty":-1.94931,"marketCap":252823111},{"date":"2025-07-25","current":-6.701186,"twenty":-7.452141,"median":-4.23371,"eighty":-1.94931,"marketCap":238075096},{"date":"2025-08-01","current":-6.407061,"twenty":-7.452141,"median":-4.242127,"eighty":-1.94931,"marketCap":221220222},{"date":"2025-08-08","current":-4.680407,"twenty":-7.452141,"median":-4.273828,"eighty":-1.94931,"marketCap":215953074},{"date":"2025-08-15","current":-4.603915,"twenty":-7.452141,"median":-4.273828,"eighty":-1.94931,"marketCap":212794985},{"date":"2025-08-22","current":-5.053389,"twenty":-7.452141,"median":-4.273828,"eighty":-1.94931,"marketCap":232810354},{"date":"2025-08-29","current":-4.986722,"twenty":-7.452141,"median":-4.273828,"eighty":-1.94931,"marketCap":230703473},{"date":"2025-09-05","current":-5.452284,"twenty":-7.453915,"median":-4.27508,"eighty":-1.949306,"marketCap":251772284},{"date":"2025-09-12","current":-4.951829,"twenty":-7.452141,"median":-4.285446,"eighty":-1.94931,"marketCap":230703473},{"date":"2025-09-19","current":-4.933801,"twenty":-7.452141,"median":-4.285446,"eighty":-1.94931,"marketCap":230703473},{"date":"2025-09-26","current":-4.70798,"twenty":-7.452141,"median":-4.296507,"eighty":-1.94931,"marketCap":218062187},{"date":"2025-10-03","current":-5.106615,"twenty":-7.452141,"median":-4.324369,"eighty":-1.94931,"marketCap":237024117},{"date":"2025-10-10","current":-5.741066,"twenty":-7.452141,"median":-4.363645,"eighty":-1.94931,"marketCap":263360130},{"date":"2025-10-17","current":-6.370512,"twenty":-7.452141,"median":-4.433688,"eighty":-1.94931,"marketCap":294963345},{"date":"2025-10-24","current":-6.451211,"twenty":-7.452141,"median":-4.469642,"eighty":-1.94931,"marketCap":297070226},{"date":"2025-10-31","current":-6.24628,"twenty":-7.452141,"median":-4.536885,"eighty":-1.94931,"marketCap":286535821},{"date":"2025-11-07","current":-4.74054,"twenty":-7.452141,"median":-4.61487,"eighty":-1.94931,"marketCap":232810354},{"date":"2025-11-14","current":-4.591644,"twenty":-7.452141,"median":-4.617864,"eighty":-1.94931,"marketCap":227545614},{"date":"2025-11-21","current":-4.417812,"twenty":-7.452141,"median":-4.622934,"eighty":-1.94931,"marketCap":217011095},{"date":"2025-11-28","current":-4.992811,"twenty":-7.452141,"median":-4.640927,"eighty":-1.94931,"marketCap":246507749},{"date":"2025-12-05","current":-4.498743,"twenty":-7.452141,"median":-4.664254,"eighty":-1.94931,"marketCap":223331807},{"date":"2025-12-12","current":-4.968906,"twenty":-7.452141,"median":-4.675134,"eighty":-1.94931,"marketCap":248614653},{"date":"2025-12-19","current":-4.425642,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":221224903},{"date":"2025-12-26","current":-4.558126,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":228599066},{"date":"2026-01-02","current":-4.256046,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":212797287},{"date":"2026-01-09","current":-4.459421,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":221224903},{"date":"2026-01-16","current":-3.368086,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":166445403},{"date":"2026-01-23","current":-3.60162,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":180140278},{"date":"2026-01-30","current":-3.318464,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":168552307},{"date":"2026-02-06","current":-3.064229,"twenty":-7.452141,"median":-4.688687,"eighty":-1.94931,"marketCap":153803980}],"updateTime":1770555495581},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRQR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601936270","title":"BRIEF-Proqr Announces Encouraging Ax-0810 Phase 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2601936270","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601936270?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:39","pubTimestamp":1767879544,"startTime":"0","endTime":"0","summary":"BRIEF-Proqr Announces Encouraging Ax-0810 Phase 1 Jan 8 (Reuters) - ProQR Therapeutics NV PRQR.O:PROQR ANNOUNCES ENCOURAGING AX-0810 PHASE 1 SAFETY AND PK DATA, DEVELOPMENT CANDIDATE SELECTIONS, AND 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA4HNXKC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2601364343","title":"ProQR Reports Positive Initial Safety Data from AX-0810 Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364343","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601364343?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:01","pubTimestamp":1767877269,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV announced encouraging initial safety and pharmacokinetic  data from the first cohort of healthy volunteers in its ongoing Phase 1 trial of AX-0810. The initial results, which showed no safety signals after four weeks of dosing and PK consistent with non-clinical data, support continued dosing in the study. Enrollment and dosing of healthy volunteers are ongoing, with target engagement data expected in the first half of 2026. Additionally, ProQR reported new non-clinical functional proof-of-concept data for AX-2911, which demonstrated over 80% reduction in hepatic fat content in a humanized PNPLA3-148M mouse model, outperforming a clinical-stage PNPLA3-directed antisense therapy. Further details and analyses on AX-2911 will be presented at a later date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL3LYXJt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B64PRP62.GBP","LU2095319765.USD","LU0314104364.USD","LU2210150020.SGD","PRQR","IE00BKPKM429.USD","SG9999014039.USD","BK4588","SG9999014013.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","IE00BGHQF748.EUR","NDAQ","BK4585","SG9999014021.USD"],"gpt_icon":0},{"id":"2601551364","title":"ProQR Therapeutics Nv: Initial Ax-0810 Data Show No Safety Signals After 4 Weeks of Dosing and Pharmacokinetics Consistent With Non-Clinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2601551364","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601551364?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:00","pubTimestamp":1767877205,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA4HNXKC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PRQR"],"gpt_icon":0},{"id":"2601364650","title":"ProQR Therapeutics Nv: Phase 1 Ax-0810 Data Expected in H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364650","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601364650?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:00","pubTimestamp":1767877205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA4HNXKC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2588720578","title":"ProQR Therapeutics to Participate in Evercore Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2588720578","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588720578?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:00","pubTimestamp":1764594033,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025, at 8:20am ET. Webcast details will be available on the company's website, with archived access for approximately 30 days following the presentation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via GlobeNewswire  on December 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL2fmNkg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","LU0314104364.USD","BK4139","EVR","LU2210150020.SGD","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","PRQR","BK4127","NDAQ","BK4588","IE00B64PRP62.GBP","BK4585","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2585466627","title":"ProQR Therapeutics N.V.'s (NASDAQ:PRQR) 29% Share Price Plunge Could Signal Some Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2585466627","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585466627?lang=en_us&edition=fundamental","pubTime":"2025-11-24 18:28","pubTimestamp":1763980109,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics N.V. ( NASDAQ:PRQR ) shareholders won't be pleased to see that the share price has had a very rough...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prqr/proqr-therapeutics/news/proqr-therapeutics-nvs-nasdaqprqr-29-share-price-plunge-coul","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prqr/proqr-therapeutics/news/proqr-therapeutics-nvs-nasdaqprqr-29-share-price-plunge-coul","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","USAW.SI","MNQmain","TQQQ","SQQQ",".IXIC","USJW.SI","PRQR","PSQ","NVIW.SI","QID","TSYW.SI","NQmain","QLD"],"gpt_icon":1},{"id":"2584692625","title":"ProQR Therapeutics Q3 EPS EUR -0.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2584692625","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584692625?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:52","pubTimestamp":1763571139,"startTime":"0","endTime":"0","summary":"Nov 06 (Reuters) - ProQR Therapeutics Q3 revenue EUR 2.882 million vs. IBES estimate EUR 4.37 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202511:00:00.293 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD1Wxn1c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2581062243","title":"ProQR Q3 revenue misses estimates, reports net loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2581062243","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581062243?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:07","pubTimestamp":1762430878,"startTime":"0","endTime":"0","summary":"ProQR Q3 revenue misses estimates, reports net lossOverviewProQR Q3 revenue missed analyst expectationsCompany reported a net loss of 11 mln for Q3 2025ProQR received CTA authorization for Phase 1 tri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL1N3WI0JZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2581062872","title":"BRIEF-ProQR Therapeutics Q3 EPS EUR -0.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2581062872","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581062872?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:00","pubTimestamp":1762430445,"startTime":"0","endTime":"0","summary":"BRIEF-ProQR Therapeutics Q3 EPS EUR -0.1\n\n\nNov 06 (Reuters) - ProQR Therapeutics Q3 revenue EUR 2.882 million vs. IBES estimate EUR 4.37 million.\n\nQ3 operating income EUR -11.284 million\nQ3 net income EUR -11.006 million\nQ3 basic EPS EUR -0.1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLXA1829E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRQR"],"gpt_icon":0},{"id":"2581064981","title":"ProQR Therapeutics Q3 Revenue EUR 2.882 Million VS. Ibes Estimate EUR 4.37 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581064981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581064981?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:00","pubTimestamp":1762430400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLXA1829E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PRQR"],"gpt_icon":0},{"id":"2579937624","title":"ProQR Therapeutics NV  expected to post a loss of 10 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2579937624","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579937624?lang=en_us&edition=fundamental","pubTime":"2025-10-31 22:44","pubTimestamp":1761921844,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV  expected to post a loss of10cents a share - Earnings Preview ProQR Therapeutics NV PRQR.OQ PRQR.O is expected to  show a rise in quarterly revenue when it reports  results on No","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL8N3WC1OO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRQR"],"gpt_icon":0},{"id":"2577793511","title":"ProQR Therapeutics NV held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2577793511","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577793511?lang=en_us&edition=fundamental","pubTime":"2025-10-24 21:24","pubTimestamp":1761312265,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV held its Annual General Meeting of Shareholders on June 3, 2025. At the meeting, shareholders approved the adoption of the annual accounts for the 2024 financial year. The proposal to grant discharge from liability to members of the Board for the performance of their duties during 2024 was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief on October 24, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nNDL3rxw5l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2576859254","title":"ProQR Therapeutics Receives CTA Authorization for Phase 1 Trial of AX-0810 in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2576859254","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576859254?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:09","pubTimestamp":1760962140,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV has received authorization from the Central Committee on Research Involving Human Subjects  for its Clinical Trial Application  to begin a Phase 1 study of AX-0810 in healthy volunteers. This approval follows review under the European Medicines Agency's centralized process. AX-0810 is ProQR's lead investigational editing oligonucleotide targeting NTCP, being developed for the treatment of cholestatic diseases such as primary sclerosing cholangitis and biliary atresia. The Phase 1 trial, to be conducted in the Netherlands, will assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of AX-0810.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nNDLc2plR2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2576859177","title":"ProQR Therapeutics Nv - Receives Cta Authorization for Phase 1 Study of Ax-0810","url":"https://stock-news.laohu8.com/highlight/detail?id=2576859177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576859177?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:05","pubTimestamp":1760961959,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nFWN3VZ048:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRQR","BK4139"],"gpt_icon":0},{"id":"2575212406","title":"ProQR Therapeutics NV to Participate in Chardan's Annual Genetic Medicines Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2575212406","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575212406?lang=en_us&edition=fundamental","pubTime":"2025-10-13 20:30","pubTimestamp":1760358628,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV will participate in Chardan's 9th Annual Genetic Medicines Conference on October 21, 2025. Company management will take part in an RNA Editing panel at 1:00 p.m. ET and hold one-on-one investor meetings during the conference. Presentations will be available on demand from October 21.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via GlobeNewswire  on October 13, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nNDL8fDM4b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","BK4585","LU0314104364.USD","NDAQ","IE00BKPKM429.USD","BK4112","PRQR","LU2210149790.SGD","LU2095319765.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2574320172","title":"ProQR Therapeutics N.V.'s (NASDAQ:PRQR) Price Is Out Of Tune With Revenues","url":"https://stock-news.laohu8.com/highlight/detail?id=2574320172","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574320172?lang=en_us&edition=fundamental","pubTime":"2025-10-10 18:25","pubTimestamp":1760091941,"startTime":"0","endTime":"0","summary":"You may think that with a price-to-sales (or \"P/S\") ratio of 13.3x ProQR Therapeutics N.V. ( NASDAQ:PRQR ) is a stock...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prqr/proqr-therapeutics/news/proqr-therapeutics-nvs-nasdaqprqr-price-is-out-of-tune-with","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prqr/proqr-therapeutics/news/proqr-therapeutics-nvs-nasdaqprqr-price-is-out-of-tune-with","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRQR",".IXIC"],"gpt_icon":0},{"id":"2557859816","title":"ProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2557859816","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557859816?lang=en_us&edition=fundamental","pubTime":"2025-08-08 01:41","pubTimestamp":1754588476,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings SummaryProQR Therapeutics NV PRQR.OQ reported a quarterly adjusted loss of 12 cents per share for the quarter ended June ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nL8N3TZ2TJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR"],"gpt_icon":0},{"id":"2557557846","title":"ProQR Q2 revenue and EPS miss estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2557557846","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557557846?lang=en_us&edition=fundamental","pubTime":"2025-08-07 19:08","pubTimestamp":1754564895,"startTime":"0","endTime":"0","summary":"ProQR Q2 revenue and EPS miss estimatesOverviewProQR Q2 revenue and EPS miss analysts' expectations, per LSEG dataCo submitted CTA for AX-0810, targeting NTCP for cholestatic diseasesProQR holds EUR11","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX950AE4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR"],"gpt_icon":0},{"id":"2556819947","title":"ProQR Therapeutics NV  expected to post a loss of 8 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2556819947","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556819947?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:31","pubTimestamp":1754055084,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV  expected to post a loss of8cents a share - Earnings Preview ProQR Therapeutics NV PRQR.OQ PRQR.O is expected to  show a fall in quarterly revenue when it reports  results on Aug","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nL8N3TT1QA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRQR"],"gpt_icon":0},{"id":"2554779650","title":"ProQR Therapeutics NV Submits CTA for AX-0810 to Target Cholestatic Diseases, Showcasing Progress in CNS Applications at Upcoming RNA Editing Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2554779650","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554779650?lang=en_us&edition=fundamental","pubTime":"2025-07-28 20:00","pubTimestamp":1753704039,"startTime":"0","endTime":"0","summary":"ProQR Therapeutics NV Submits CTA for AX-0810 to Target Cholestatic Diseases, Showcasing Progress in CNS Applications at Upcoming RNA Editing Summit. ProQR Therapeutics NV has announced a significant milestone in their ongoing development of RNA therapies. The company has submitted a Clinical Trial Application  for their product AX-0810, which targets NTCP for the treatment of cholestatic diseases. This submission marks a key step forward for ProQR as they continue to advance their proprietary Axiomer RNA editing technology platform. The news comes ahead of ProQR's upcoming presentation at the RNA Editing Summit in Boston, where further details on their CNS applications and Rett program will be discussed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nNDLc7bnNj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","IE00B64PRP62.GBP","LU2210149790.SGD","PRQR","IE00BKPKM429.USD","NDAQ","BK4588","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4585","BK4139","BK4112"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}